My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BioCardia, Inc. - Common Stock (NQ:BCDA)

1.370 +0.090 (+7.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioCardia, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

BioCardia (BCDA) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

BioCardia (BCDA) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

BioCardia Inc (NASDAQ:BCDA) Reports Q3 2025 Results, Posts Wider Loss Amid Challenging Month ↗

November 12, 2025

BioCardia reports Q3 2025 results with no revenue and a wider-than-expected loss. The clinical-stage biotech continues advancing its cell therapy pipeline for heart failure.

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Earnings Outlook For BioCardia ↗

November 11, 2025

Via Benzinga

Unusual volume stocks are being observed in Tuesday's session. ↗

September 23, 2025

On Tuesday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

September 18, 2025

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

Peering Into BioCardia's Recent Short Interest ↗

September 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 18, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

September 18, 2025

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Gold Falls Over 1%; Darden Posts Downbeat Earnings ↗

September 18, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Thursday's session. ↗

September 18, 2025

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Why BioCardia (BCDA) Stock Is Falling Today ↗

August 30, 2024

BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering.

Via Benzinga

Nasdaq Surges 100 Points; US Initial Jobless Claims Fall ↗

September 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 18, 2025

Via Benzinga

BioCardia Narrows Loss in Fiscal Q2 ↗

August 11, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 02, 2025

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 16, 2025

Via Benzinga

Earnings Scheduled For March 26, 2025 ↗

March 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 04, 2024

Via Benzinga

Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

August 30, 2024

Via Benzinga

Crude Oil Moves Higher; Dollar General Earnings Miss Estimates ↗

August 29, 2024

Via Benzinga

Topics Earnings

Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings ↗

August 29, 2024

Via Benzinga

Dow Jumps Over 100 Points; Nvidia Earnings Top Views ↗

August 29, 2024

Via Benzinga

Topics Stocks

Why BioCardia (BCDA) Stock Is Up 95% Today ↗

August 29, 2024

BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family.

Via Benzinga

Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

August 29, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.